首页> 外文OA文献 >Circulating tumor DNA as a biomarker in metastatic melanoma patients treated with anti-PD1 antibodies

【2h】

Circulating tumor DNA as a biomarker in metastatic melanoma patients treated with anti-PD1 antibodies

机译：抗PD1抗体治疗的转移性黑色素瘤患者中循环肿瘤DNA作为生物标记物

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lee J; Boyd S; Tembe V; Menzies A; Long G; Guminski A; Kefford R; Carlino M; Rizos H;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy [J] . Teofila Seremet, Yanina Jansen, Simon Planken, Journal of Translational Medicine . 2019,第1期

机译：未检测到的循环肿瘤DNA（CTDNA）水平与用抗PD1治疗治疗的转移性黑色素瘤患者的有利结果相关
2. Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma [J] . Lee J. H., Long G. V., Boyd S., Annals of oncology: official journal of the European Society for Medical Oncology . 2017,第5期

机译：循环肿瘤DNA预测转移性黑色瘤中的抗PD1抗体的反应
3. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma [J] . Uryvaev Anton, Passhak Maria, Hershkovits Dov, Medical oncology . 2018,第3期

机译：肿瘤浸润淋巴细胞（TIL）的作用作为转移性非小细胞肺癌或转移性黑素瘤患者抗PD1治疗的预测生物标志物
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Associating Computed Tomography (CT) Imaging Response Criteria and Texture Analysis Measurements with Survival in Patients with Metastatic Melanoma Treated with Anti-angiogenic Therapy. [D] . Gray, Mark Russell. 2014

机译：将计算机断层扫描（CT）成像反应标准和纹理分析测量值与接受抗血管生成治疗的转移性黑色素瘤患者的生存率相关联。
6. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy [O] . Teofila Seremet, Yanina Jansen, Simon Planken, 2019

机译：抗PD1疗法治疗的转移性黑色素瘤患者无法检测到的循环肿瘤DNA（ctDNA）水平与良好的预后相关
7. Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies [O] . Jenny H. Lee, Georgina V. Long, Alexander M. Menzies, 2018

机译：用反向细胞死亡1抗体治疗转移性黑素瘤患者循环肿瘤DNA和假冒竞争的关联

Circulating tumor DNA as a biomarker in metastatic melanoma patients treated with anti-PD1 antibodies

著录项

引文网络

相似文献

相关主题

期刊订阅